- cafead Jul 13, 2023 at 09:12: PM
via Business Weekly reported in March that the company would be looking to generate more growth funding despite having $339.2 million cash – a runway to take the Nasdaq-quoted company into 2025.
The company has grown headcount and facilities in the UK and in the Boston cluster in the US and its drug pipeline is accelerating fast.
article source
The company has grown headcount and facilities in the UK and in the Boston cluster in the US and its drug pipeline is accelerating fast.
article source